Search Results - "Sánchez Hidalgo, J. M."

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma by Arjona-Sánchez, A, Barrios, P, Boldo-Roda, E, Camps, B, Carrasco-Campos, J, Concepción Martín, V, García-Fadrique, A, Gutiérrez-Calvo, A, Morales, R, Ortega-Pérez, G, Pérez-Viejo, E, Prada-Villaverde, A, Torres-Melero, J, Vicente, E, Villarejo-Campos, P, Sánchez-Hidalgo, J M, Casado-Adam, A, García-Martin, Ruben, Medina, Manuel, Caro, T, Villar, C, Aranda, Enrique, Cano-Osuna, M T, Díaz-López, C, Torres-Tordera, E, Briceño-Delgado, F J, Rufián-Peña, S

“…Local relapse and peritoneal carcinomatosis (PC) for pT4 colon cancer is estimated in 15,6% and 36,7% for 12 months and 36 months from surgical resection…”
Get full text

Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial by Pontes-García, A., Martínez-López, A., Rodríguez-Ortiz, L., Valenzuela-Molina, F., Rufián-Andújar, B., Sánchez-Hidalgo, J.M., Casado-Adam, A., Gordon-Suarez, A., Rufián-Peña, S., Vázquez-Borrego, M.C., Romero-Ruiz, A., Arjona-Sánchez, A.

“…Neutral argon plasma (NAP) system could meet the requirements to achieve oncological cytoreduction of peritoneal carcinomatosis with miliary lesions,…”
Get full text

Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center by Muñoz-Casares, F.C, Medina-Fernández, F.J, Arjona-Sánchez, Á, Casado-Adam, Á, Sánchez-Hidalgo, J.M, Rubio, M.J, Ortega-Salas, R, Muñoz-Villanueva, M.C, Rufián-Peña, S, Briceño, F.J

“…Abstract Background Cytoreductive surgery with peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) represents a radical…”
Get full text

Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances by Arjona-Sánchez, A, Cadenas-Febres, A, Cabrera-Bermon, J, Muñoz-Casares, F.C, Casado-Adam, A, Sánchez-Hidalgo, J.M, López-Andreu, M, Briceño-Delgado, J, Rufián-Peña, S

“…Abstract Background The acute renal dysfunction (ARD) is a common complication in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)…”
Get full text

Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy by Arjona-Sánchez, A., Cortés-Guiral, D., Duran-Martínez, M., Villarejo-Campos, P., Sánchez-Hidalgo, J. M., Casado-Adam, A., Rodriguez-Ortiz, L., Romero-Ruiz, A., Rufian-Andujar, B., Espinosa-Redondo, E., Valenzuela-Molina, F., Rufián-Peña, S., Briceño-Delgado, J.

“…Background The aim of our study was to present the technique for, and early results of complete laparoscopic pelvic peritonectomy (LPP) plus hyperthermic…”
Get full text

“Super-rapid” Technique in Donation After Circulatory Death Liver Donors: Advantages and Disadvantages by Sánchez-Hidalgo, J.M., Rodríguez-Ortiz, L., Arjona-Sánchez, Á., Ayllón-Terán, M.D., Gómez-Luque, I., Ciria-Bru, R., Luque-Molina, A., López-Cillero, P., Rufián-Peña, S., Briceño-Delgado, J.

“…In recent years, donation after circulatory death (DCD) has increased as an option to overcome the organ donor shortage crisis and to decrease the large number…”
Get full text

Pancreas Donor Hypernatremia: Is it Really a Risk Factor for Simultaneous Pancreas-kidney Transplantation? by Sánchez-Hidalgo, J.M., Rodríguez-Ortiz, L., Arjona-Sánchez, A., Ruiz-Rabelo, J., Salamanca-Bustos, J.J., Rodríguez-Benot, A., Márquez-López, F.J., Briceño-Delgado, J.

“…Solid organ donor hypernatremia has been classically reported to be a risk factor for cell lysis and graft damage. National criteria for pancreatic donation…”
Get full text

Intraoperative Heparinization During Simultaneous Pancreas-Kidney Transplantation: Is It Really Necessary? by Arjona-Sánchez, A., Rodríguez-Ortiz, L., Sánchez-Hidalgo, J.M., Ruiz Rabelo, J., Salamanca-Bustos, J.J., Rodríguez-Benot, A., Campos-Hernández, P., Briceño-Delgado, J.

“…The use of intraoperative sodium heparin during simultaneous pancreas-kidney transplantation (SPKT) remains as a routine practice in some referral centers to…”
Get full text

What Is the Influence of Both Risk Donor and Risk Receiver on Simultaneous Pancreas-Kidney Transplantation? by Sánchez-Hidalgo, J.M., Salamanca-Bustos, J.J., Arjona-Sánchez, Á., Campos-Hernández, J.P., Ruiz Rabelo, J., Rodríguez-Benot, A., Requena-Tapia, M.J., Briceño-Delgado, J.

“…Some factors affect the pancreas of a marginal donor, and although their influence on graft survival has been determined, there is an increasing consensus to…”
Get full text

Validation of the Pancreatic Donor Risk Index in Simultaneous Pancreas-Kidney Transplantation Performed in Córdoba Hospital From 2000 to 2015 by Salamanca-Bustos, J.J, Campos-Hernandez, J.P, Sánchez-Hidalgo, J.M, Arjona-Sánchez, A, Sánchez-González, A, Arenas-Bonilla, A.J, Ruiz-Rabelo, J, Carrasco-Valiente, J, Ruiz-García, J, Regueiro-López, J.C, Briceño-Delgado, J, Requena-Tapia, M.J

“…Abstract Background The Pancreatic Donor Risk Index (PDRI) was developed in 2010 in the United States to predict graft survival after pancreas transplantation,…”
Get full text

Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience by Arjona-Sanchez, A., Rufian-Peña, S., Sanchez-Hidalgo, J. M., Casado-Adam, A., Cosano-Alvarez, A., Briceño-Delgado, J.

“…Background The cytoreductive surgery (CRS) associated with hyperthermic intraperitoneal chemotherapy (HIPEC) has become the standard treatment in patients with…”
Get full text

Model for End-stage Liver Disease Can Predict Very Early Outcome After Liver Transplantation by Briceño, J, Sánchez-Hidalgo, J.M, Naranjo, A, Ciria, R, Pozo, J.C, Luque, A, de la Mata, M, Rufián, S, López-Cillero, P

“…Abstract Postoperative Model for End-stage Liver Disease (MELD) values have never been assessed to predict very early (<1 week) death after liver…”
Get full text

Establishment of a Pediatric Liver Transplantation Program: Experience With 100 Transplantation Procedures by Ciria, R, Sánchez-Hidalgo, J.M, Briceño, J, Naranjo, Á, Pleguezuelo, M, Díaz-Nieto, R, Luque, A, Jiménez, J, García-Menor, E, Gilbert, J.J, de la Mata, M, Pérez-Navero, J.L, Solórzano, G, Rufián, S, Pera, C, López-Cillero, P

“…Abstract Objective To analyze the primary factors that influence the development and consolidation of a pediatric liver transplantation program. Patients and…”
Get full text

Prediction Model to Discard A Priori Liver Allografts by Arjona-Sánchez, A, Sánchez-Hidalgo, J.M, Ciria-Bru, R, Muñoz-Casares, F.C, Ruiz-Rabelo, J.F, Gallardo, A, Orti, R, Luque, A, Rufián-Peña, S, López-Cillero, P, de la Mata, M, Briceño-Delgado, F.J

“…Abstract Background The use of expanded criteria for donors to expand the donor pool has increased the number of discarded liver grafts in situ. The aim of our…”
Get full text

Laparoscopic Living Donor Hepatectomy for Pediatric Liver Transplantation: the First 7 Cases in Spain by Briceno, J., Ciria, R., López, P., Luque, A., Arjona-Sanchez, A., Sánchez-Hidalgo, J.M., Ayllón, M.D., Gómez-Luque, I., Gomez, J.

“…Herein we report on laparoscopic donor hepatectomy (left lateral sectionectomy) for pediatric living donor liver transplantation by using a pure laparoscopic…”
Get full text

Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry by Arjona-Sanchez, A., Aziz, O., Passot, G., Salti, G., Esquivel, J., Van der Speeten, K., Piso, P., Nedelcut, D.-S., Sommariva, A., Yonemura, Y., Turaga, K., Selvasekar, C.R., Rodriguez-Ortiz, L., Sanchez-Hidalgo, J.M., Casado-Adam, A., Rufian-Peña, S., Briceño, J., Glehen, O.

“…A laparoscopic approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (L-CRS+HIPEC) in highly selected patients has been reported in…”
Get full text

RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score by Arjona-Sanchez, A., Rodriguez-Ortiz, L., Baratti, D., Schneider, M. A., Gutiérrez-Calvo, A., García-Fadrique, A., Tuynman, J. B., Cascales-Campos, P. A., Martín, V. Concepción, Morales, R., Salti, G. I., Arteaga, X., Pacheco, D., Alonso-Gomez, J., Yalkin, O., Villarejo-Campos, P., Sanchez-Hidalgo, J. M., Casado-Adam, A., Cosano-Alvarez, A., Rufian-Peña, S., Briceño, J.

“…Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are currently the most accepted treatment for peritoneal…”
Get full text

Carney's triad: case report and review by Díaz Nieto, R, Arjona Sánchez, A, Gómez Alvarez, M, Martínez Cecilia, D, Sánchez Hidalgo, J M, Ciria Bru, R, Pérez Manrique, M C, Sánchez Rodríguez, J, Rufián Peña, S

“…Carney's triad is a rare pathogenic entity which consists of the association in young women of multiple condromatosis in the lung, gastric leiomyosarcoma, and…”
Get full text

Pancreatic metastases from renal cell carcinoma by Gómez Dueñas, G., Calleja Lozano, R., Arjona Sánchez, A., Sánchez Hidalgo, J.M., Espinosa Redondo, M.E., Rodríguez Ortiz, L., Briceño Delgado, F.J.

Get full text

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification by Arjona-Sanchez, A, Martinez-López, A, Moreno-Montilla, M T, Mulsow, J, Lozano-Lominchar, P, Martínez-Torres, B, Rau, B, Canbay, E, Sommariva, A, Milione, M, Deraco, M, Sgarbura, O, Torgunrud, A, Kepenekian, V, Carr, N J, Hoorens, A, Delhorme, J B, Wernert, R, Goere, D, Martin-Roman, L, Cosyns, S, Flatmark, K, Davidson, B, Khellaf, L, Pereira-Perez, F, Rodriguez-Ortiz, L, Ibáñez-Costa, A, Romero-Ruiz, A

“…Pseudomyxoma peritonei (PMP) is a rare malignant disease. Adding of the Ki67 proliferation index to the PSOGI PMP classification provided two different…”
Get full text